Streetbeat News

Dividends

MACK

Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) announced the approval of a Plan of Dissolution by its stockholders and declared a liquidating cash dividend of $15.10 per share, to be paid on May 17, 2024. The company's stock will continue to trade on NASDAQ until May 17, 2024, and will be delisted on May 20, 2024. Future distributions are possible if reserved amounts are deemed unnecessary or if additional milestones under existing agreements are achieved.

Portfolio Pulse from Benzinga Newsdesk

May 10, 2024 | 8:36 pm

HBB

Hamilton Beach Brands Holding Company (NYSE:HBB) has announced a 4.5% increase in its regular quarterly cash dividend, raising it from $0.11 to $0.115 per share, payable on June 14, 2024, to stockholders of record as of May 31, 2024.

Portfolio Pulse from Benzinga Newsdesk

May 10, 2024 | 8:22 pm

AUMN

HAYN

MTUS

AngloGold Ashanti reports a 2% increase in Q1 2024 gold production, maintaining full-year guidance despite challenges. Golden Minerals sells Velardeña Properties assets for $5.5 million. Metallus announces Q1 results with $321.6 million in net sales and a new $100 million share buyback program. Haynes Intl's fiscal Q2 net revenues hold steady at $152.5 million, with a net income of $8.6 million.

Portfolio Pulse from austin@walkonholdings.com

May 10, 2024 | 8:00 pm

BAYRY

GOOG

IBM

INTC

MSFT

NVDA

AI is significantly impacting the pharmaceutical industry, from drug discovery to marketing, with Alphabet Inc's Google DeepMind developing AlphaFold 3, an AI model that predicts the structure of biological molecules. McKinsey reports AI could generate $60 billion-$110 billion annually for the industry, speeding up drug discovery and development. Collaborations like Bayer AG and Google Cloud are developing AI solutions for healthcare. Key players include Nvidia, Intel, IBM, Google, GE, Microsoft, Medtronic, Micron Technology, Amazon Web Services, and Siemens Healthineers.

Portfolio Pulse from Vandana Singh

May 10, 2024 | 6:49 pm

MAR

Marriott International, Inc. (NASDAQ:MAR) has announced a 21% increase in its quarterly cash dividend, from $0.52 to $0.63 per share, payable on June 28, 2024, to shareholders of record as of May 24, 2024. This increase reflects the company's earnings growth and strong cash generation.

Portfolio Pulse from Benzinga Newsdesk

May 10, 2024 | 4:32 pm

Curtiss-Wright has increased its share repurchase authorization from $300M to $400M and raised its dividend from $0.20 to $0.21 per share.

Portfolio Pulse from Benzinga Newsdesk

May 10, 2024 | 1:26 pm

CRH

CRH plc (NYSE:CRH) shares rose in premarket trading after reporting positive Q1 FY24 results, including a 2% revenue increase to $6.5 billion and the announcement of a share repurchase program. Adjusted EBITDA increased by 15% to $445 million, with an EPS of $0.16 compared to a loss in the previous year. The company also declared a quarterly dividend of $0.35 per share and continues to project favorable market conditions and positive pricing momentum for FY24.

Portfolio Pulse from Lekha Gupta

May 10, 2024 | 1:03 pm

PFX

PhenixFIN has declared a special dividend of $1.31 per share, according to an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

May 10, 2024 | 12:43 pm

BMY

OGN

PFE

Wall Street's most accurate analysts have provided updates on three health care stocks with over 5% dividend yields: Pfizer Inc. (PFE), Organon & Co. (OGN), and Bristol-Myers Squibb Company (BMY). These updates include changes in price targets and ratings, reflecting the analysts' views on the stocks' future performance. Additionally, recent news relevant to each company is highlighted, such as Pfizer's settlement of lawsuits and Organon's senior notes offering.

Portfolio Pulse from Avi Kapoor

May 10, 2024 | 12:01 pm

METC

PLL

RGLD

Piedmont Lithium (PLL) reported a record quarter with 40,439 dmt produced and $13.4 million in revenue. Ramaco Resources (METC) faced lower net income due to decreased coal prices and higher costs. Royal Gold (RGLD) increased its liquidity after a strong quarter, with net income of $47.2 million. Tredegar Corp (TG) reported a net income of $3.3 million, recovering from a loss, and is selling its Terphane division.

Portfolio Pulse from austin@walkonholdings.com

May 09, 2024 | 10:42 pm